Skip to content

Comparison of nalbuphine and dexmedetomidine for blunting intubation response

Comparison of nalbuphine and dexmedetomidine for attenuation of haemodynamic response to laryngoscopy and intubation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012707
Enrollment
80
Registered
2018-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients undergoing elective surgery under general anaesthesia and requiring endotracheal intubation

Interventions

Intervention1: Nalbuphine: Patients will receive 0.2 µg/kg of nalbuphine diluted to 10 ml with 0.9% saline solution over a period of 10 minutes before induction of anaesthesia. Control Intervention1:

Sponsors

University College of Medical Sciences and Guru Teg Bahadur Hospital Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients undergoing elective surgery under general anaesthesia and requiring endotracheal intubation 2 Patients belonging to American Society of Anesthesiologist (ASA) grade I and II 3 Patients of either gender 4 Patients between 18-60 years of age 5 Patients between 40-70 kg of weight 6 Modified Mallampati Grade I and II

Exclusion criteria

Exclusion criteria: 1 Patientâ??s refusal 2 Patients with history of allergy to opioids, difficult intubation or sleep apnea 3 Patients with history of cardiovascular, cerebral, renal, hepatic, bronchospastic or endocrine disease or psychiatric disorder. 4 Patients on anti hypertensives, hypnotic or narcotic analgesics 5 Patients with anticipated difficult airway (Modified Mallampatti grade III and IV, thyromental distance 6 Full stomach patients, pregnant and lactating females.

Design outcomes

Primary

MeasureTime frame
Change in heart rate (HR) and systolic blood pressure (SBP)Timepoint: Tb: Baseline in OT Td: After test drug administration over 10 minutes Tp: After propofol administration Tv: 3 minutes after vecuronium administration T0: At the time of intubation T1: 1 minute after endotracheal intubation T3: 3 minutes after endotracheal intubation T5: 5 minutes after endotracheal intubation T10: 10 minutes after endotracheal intubation T15: 15 minutes after endotracheal intubation Thereafter, every 15 minutes till the end of surgery. Upto 24 hrs

Secondary

MeasureTime frame
1 Change in diastolic blood pressure (DBP) and mean arterial pressure (MAP) 2 Side effects of the two study drugsTimepoint: Tb: Baseline in OT Td: After test drug administration over 10 minutes Tp: After propofol administration Tv: 3 minutes after vecuronium administration T0: At the time of intubation T1: 1 minute after endotracheal intubation T3: 3 minutes after endotracheal intubation T5: 5 minutes after endotracheal intubation T10: 10 minutes after endotracheal intubation T15: 15 minutes after endotracheal intubation Thereafter, every 15 minutes till the end of surgery. Upto 24 hrs

Countries

India

Contacts

Public ContactAkanksha Rathore

University College of Medical Sciences and GTB Hospital

sujatac462@gmail.com9868399705

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026